Firma Pierre Fabre Dermo-Kosmetik, Autor bei News-Research

Aglaia Therapeutics becomes Ribonexus, signs exclusive license agreement with Pierre Fabre on small molecules targeting eIF4A, an innovative target in oncology

18. November 202118. November 2021 Firma Pierre Fabre Dermo-KosmetikPosted in Gesundheit & MedizinTagged afb, cancer, cellular, clinical, fabres, financial, medical, mrna, mutuel, new, patients, rna, series, therapeutics, with

Ribonexus (previously Aglaia Therapeutics), a biotechnology startup developing promising new therapies that can overcome resistance to current targeted therapies in cancer patients, and French pharmaceutical group Pierre Fabre today announce […]